[ÕªÒª] Ä¿µÄ ¶Ô¸ßλʳ¹Ü°©Ê³¹ÜÖ§¼ÜÖÃÈëµÄÁÙ´²ÁÆÐ§½øÐй۲죬²¢¶ÔÖ§¼ÜÖÃÈë·½·¨½øÐÐ̽ÌÖ¡£·½·¨ 25Àý¸ßλʳ¹Ü°©»¼Õߣ¬³õÆÚµÄ8Àý²ÉÓÃÆÕͨ¹ú²úÖÃÈëÆ÷ÖÃÈ룻ºóÆÚµÄ17Àý£¬¶ÔÖÃÈëÆ÷е½øÐÐÁ˸ÄÁ¼¡£½á¹û 3ÀýÖ§¼ÜÖÃÈëºó³öÏÖÃ÷ÏÔµÄÍÌÑÊÌÛÍ´£¬Áí22Àý½öÓоֲ¿Çá¶ÈÌÛÍ´²»ÊʺÍÒìÎï¸Ð£¬Ò»ÖܺóÖð½¥¼õÇáºÍÏûʧ£¬ÊõºóÍÌÑÊÀ§ÄÑÃ÷ÏÔ»º½â¡£½áÂÛ ¸ßλʳ¹Ü°©Ö§¼ÜÖÃÈëҪעÒâÒÔϼ¸¸öÎÊÌ⣺1.Ö§¼ÜÉ϶˲»Ó¦³¬¹ýC7 ×µÌåÆ½Ãæ£»2.Ö§¼ÜÓ¦ÖʵØÈáÈí£¬×îºÃÑ¡ÔñÉ϶˱¿Ú×´»òÇòͷʽ֧¼Ü£»3.Ö§¼ÜµÄ¿Ú¾¶ÒÔ²»³¬¹ý15mmΪÒË£¬Òª×¢Òâ¶ÔÆø¹ÜµÄѹÆÈ£» 4.¸ÄÁ¼µÄÖÃÈë×°ÖÃÓÐÖúÓÚÊõÖÐËæÊ±µ÷ÕûÖ§¼ÜλÖã¬Ê¹¶¨Î»¸ü׼ȷ¡£
[¹Ø¼ü´Ê] ʳ¹ÜÏÁÕ£»¸ßλ£»Ê³¹ÜÖ×Áö£»Ö§¼Ü£»·½·¨
[Abstract] Objective To observe the therapeutic efficiency of stent implantation in upper esophageal cancer£¬and to research the methods of implanting techniques. Methods 25 cases with upper esophageal cancer were treated by implanting metallic stents, of which improved implanting instrument were used in 17 cases. Results Dysphagia alleviated or disappeared after stent implantation in most of the cases. Severe pain when swallow after the operation happened in 3 cases. Conclusion 1. The stent should not surpass the height of C7 ; 2. The upper end of the stent should be cup or ball shaped; 3. Pay attention not to press the trachea by the stent; 4. Improved stent implanting instrument is favourable for accurate positioning of the stent.
[Key words] Upper esophageal stenosis; Esophageal tumor; Stent; Method
ʳ¹ÜÖ§¼ÜµÄÓ¦ÓÃΪÖÐÍíÆÚʳ¹Ü°©»¼ÕßÌṩÁËÒ»ÖÖ΢´´ºÍÓÐЧµÄÖÎÁÆ·½·¨£¬Á¢¸Í¼ûÓ°µØ¸ÄÉÆÁË»¼ÕßÍÌÑÊÀ§ÄѵÄÖ¢×´¡£½üÄêÀ´£¬ËäȻʳ¹ÜÖ§¼ÜµÄÖÃÈë¼¼ÊõÒÑÈÕ½¥³ÉÊìºÍÆÕ¼°£¬µ«¸ßλʳ¹Ü°©ÒòÆäÌØÊâµÄ½âÆÊ²¿Î»£¬¶ÔÖ§¼ÜÖÃÈë¼¼ÊõÒªÇó½Ï¸ß£¬´¦Àí²»µ±²¢·¢Ö¢Ò²½Ï¶à¡£±¾ÎÄÖØµã¶Ô¸ßλʳ¹Ü°©Ö§¼ÜÖÃÈëµÄÁÙ´²ÁÆÐ§½øÐй۲죬²¢¶ÔÖ§¼ÜÖÃÈë·½·¨½øÐÐ̽ÌÖ¡£
×ÊÁϺͷ½·¨
1.ÁÙ´²×ÊÁÏ
1997Äê2ÔÂÖÁ2006Äê12Ô£¬ÎÒÃǶÔ368Àýʳ¹Ü°©»¼ÕßÊ©ÐÐÁËʳ¹ÜÖ§¼ÜÖÃÈëÊõ£¬Öص㱨¸æÆäÖÐ25Àý¸ßλʳ¹Ü°©£¨ÏÁÕÉ϶˴ïÐØÀªÈë¿Ú´¦»òÒÔÉÏ£©£¬ÄÐ10Àý£¬Å®6Àý£¬ÄêÁä54-78Ëê¡£ÆäÖÐ4ÀýºÏ²¢ÓÐʳ¹ÜÆø¹Üðü¡£
2.Ö§¼ÜÖÃÈë·½·¨
ÔÚX Ïß¼àÊÓϽøÐС£²ÉÓùú²úÄøîѺϽðÖ§¼Ü¡£³õÆÚµÄ8ÀýÓÃÆÕͨ¹ú²úÖÃÈëÆ÷¡£ºóÆÚÎÒÃÇ¶ÔÆ÷е½øÐÐÁ˸ÄÁ¼£¬Ê¹Ö§¼Ü¶¨Î»¸ü׼ȷ¡£¸ÄÁ¼µÄÖÃÈëÆ÷е°üÀ¨Ò»¸öÖ±¾¶8.£µmmµÄÍâÇʹܡ¢Ò»¸öÍ·¶ËÈáÈí½¥Ï¸µÄÄÚо£¬ÄÚоÓп׿Éͨ¹ýµ¼Ë¿¡£Í¸ÊÓϵ½Î»ºó³é³öÄÚо£¬±£ÁôÍâÇʹܡ£½«Ö§¼Ü½ü¶ËÌ×ÉÏË¿Ïߣ¬ÓÃÀ´ÔÚÊõÖе÷ÕûÖ§¼ÜλÖá£ÏȽ«Ö§¼Ü×°ÈëÒ»¸ö3¡«5cm³¤µÄÖÃÈëСÌ×¹ÜÄÚ£¬Ê¹Ö§¼ÜÏȶËËõ½øÐ¡Ì׹ܣ¬Ð¡Ì׹ܶÔ×¼ÍâÇʹܣ¬ÊÖÍÆÖ§¼Üβ¶Ë£¬Ö§¼ÜÏȶ˼´Ë³Àû½øÈëÍâÇʹÜÄÚ¡£ÕâʱÔÙÓÃÖ±¾¶6.£µmmµÄÍÆË͹ܲåÈëÍâÇʹܣ¬ÓÃÍÆË͹ÜÍÆËÍÖ§¼ÜÔÚÍâÇʹÜÄÚǰ½ø¡£Í¸ÊÓÏÂÖ§¼Ü¶¨Î»×¼È·ºó¹Ì¶¨ÍÆË͹ܣ¬ºóÍËÍâÇʹܣ¬Ö§¼Ü¼´Ë³ÀûÊÍ·Å¡£ÊͷŹý³ÌÖз¢ÏÖÖ§¼ÜλÖÃÓÐÆ«²îʱ£¬¿ÉÀ½ôÔ¤ÁôÔÚÍÆË͹ÜÄÚµÄË¿Ïߣ¬Ê¹Ö§¼ÜËõ½øÍâÇʹܣ¬¿É·Ç³£·½±ãµØÏòÉÏ»òÏòϵ÷ÕûÖ§¼ÜλÖá£Ö§¼ÜÖÃÈëºó£¬Ë¿Ïß±£Áô24Сʱ£¬¹Û²ìÖ§¼ÜÎÞÒÆÎ»Ê±Í˳öË¿Ïß¡£
½á¹û
Ö§¼ÜÖÃÈë¹ý³ÌÈ«²¿Ë³Àû£¬25ÀýÖÐÓÐ3ÀýÖ§¼ÜÖÃÈëºó³öÏÖÃ÷ÏÔµÄÍÌÑÊÌÛÍ´£¬ÓÃÕòÍ´Ò©²»ÄÜ»º½â¡£Õâ3Àý¾ùÊdzõÆÚʹÓÃÆÕͨÖÃÈëÆ÷·ÅÖõÄÖ§¼Ü£¬Ö§¼ÜλÖþù±ÈÔ¤¼ÆµÄλÖÃÆ«¸ß£¬Ö§¼ÜÊͷŵ½Ò»¶¨³Ì¶ÈºóλÖü´ÄÑÒÔÉÏϵ÷Õû¡£Áí22ÀýÊõºó½öÓоֲ¿Çá¶ÈÌÛÍ´²»ÊʺÍÒìÎï¸Ð£¬Ò»ÖܺóÖ¢×´Öð½¥¼õÇáºÍÏûʧ¡£Ö§¼ÜÖÃÈëºóÍÌÑÊÀ§ÄѼ´¿Ì»º½â£¬Äܽø°ëÁ÷ʳºÍÆÕʳ¡£4Àý²¢ÓÐʳ¹ÜÆø¹ÜðüµÄ»¼Õß¼ÓĤʳ¹ÜÖ§¼ÜÖÃÈëºóǺ¿ÈÖ¢×´¼´¿ÌÏûʧ£¬ÍÌÑÊÀ§ÄÑ»º½â¡£
ÌÖ ÂÛ
ÍíÆÚʳ¹Ü°©Ê¹60%µÄ»¼ÕßʧȥÁËÍâ¿ÆÊÖÊõÇгýµÄ»ú»á[1]¡£Ê³¹ÜÖ§¼ÜÖÃÈëÊõÒÑÓúÀ´Óú¹ã·ºµØÓ¦ÓÃÓÚÁÙ´²[1~4]¡£¸ßλʳ¹Ü°©ÒòÆäÌØÊâµÄ½âÆÊ²¿Î»£¬¶Ôʳ¹ÜÖ§¼Ü¶¨Î»¼¼ÊõÓÐןüΪÑϸñµÄÒªÇó¡£Ò»µ©·¢ÉúÖ§¼ÜλÖÃÆ«²î£¬½«»áÒýÆðÍÌÑÊÌÛÍ´£¬»áÑṦÄÜʧµ÷£¬ºôÎüÀ§ÄѵȲ¢·¢Ö¢£¬ÎÒÃÇÈÏΪÉ϶Îʳ¹Ü°©µÄÖ§¼ÜÖÃÈëӦעÒâÒÔϼ¸¸öÎÊÌâ¡£
1ÊÊÓ¦Ö¢µÄÑ¡Ôñ
¹ØÓÚÉ϶Îʳ¹Ü°©¸ß´ïºÎÖ̶ֳȼ´Ó¦ÊÓΪʳ¹ÜÖ§¼ÜµÄ½û¼ÉÖ¢£¬ÎÄÏ×ÖÐÉÐÎÞͳһ±ê×¼¡£ÓÐѧÕßÈÏΪ£¬Ö§¼ÜµÄ½ü¿Ú¶ËÓ¦ÖÃÓÚÀæ×´ÎÑÒÔÏÂ[3]¡£Ò²ÓÐÈËÈÏΪ֧¼ÜÉÏÔµ²»Òª³¬¹ý¾±7×µÌåÆ½Ãæ[4]¡£Ê³¹ÜÉ϶ËÔÚµÚ6¾±×µË®Æ½ÓëÑÊÏà½Ó£¬ÊÇʳ¹ÜµÄµÚÒ»ÉúÀíÏÁÕËùÔÚ[5]¡£ÉúÀíÇé¿öÏ£¬Ê³¹ÜÉ϶ËËæÍÌÑʶ¯×÷ÉÏÏÂÒÆ¶¯¡£ÈôÖ§¼ÜÉ϶˴ﵽÉõÖÁ¸ßÓÚÕâÒ»²¿Î»Ê±£¬ÊƱػáÒýÆðÖ§¼ÜÖÃÈëºóµÄÍÌÑÊÌÛÍ´£¬ÉõÖÁÓ°Ïì»áÑṦÄÜ¡£ÓÉÓÚÀæ×´ÎÑÊõÖв»Ò×¶¨Î»£¬ÇÒÆäλÖÃËæÍÌÑʶ¯×÷ÉÏÏÂÒÆ¶¯£¬¶ø¾±×µÏÔ¶øÒ×¼û£¬Î»ÖÃÏà¶Ô¹Ì¶¨£¬Òò´ËÎÒÃÇÈÏΪʳ¹ÜÖ§¼ÜÉ϶ËÓ¦ÒÔ¾±7×µÌåÆ½ÃæÎª×î¸ß½çÏÞ¡£Ô¤¼ÆÖ§¼ÜÉ϶ËÐ賬³öÕâÒ»Æ½ÃæÊ±£¬¿É²ÉÓÃÇòÄÒÀ©ÕŹÃÏ¢ÖÎÁÆ¡£
2Ö§¼ÜµÄÑ¡Ôñ
ʳ¹ÜÉ϶ζÔÌÛÍ´½ÏÃô¸Ð[6]£¬¶ÔÉ϶Îʳ¹Ü°©£¬³ýӦעÒâÖ§¼ÜÉ϶ËλÖò»Äܹý¸ßÍ⣬֧¼ÜµÄÑ¡ÔñÒ²·Ç³£ÖØÒª¡£Ö§¼ÜµÄÖʵØÒª±È½ÏÈáÈí£¬É϶˵ÄÐÎ̬²»Ò˲ÉÓÃÀ®°È¿Ú×´¡£²ÉÓÃÉ϶ËΪ±¿ÚÐκÍÇòͷʽ֧¼ÜÊõºóÌÛÍ´ºÍ²»ÊʸÐÃ÷ÏÔ¼õÇá¡£×î½üÎÒÃÇ»¹½«ÄϾ©Î¢´´¹«Ë¾Éú²úµÄ»úÖ¯Ö§¼ÜÊÔÓÃÓÚÉ϶Îʳ¹ÜÏÁյϼÕߣ¬ÕâÖÖÖ§¼Ü±àÖ¯·½·¨ÌØÊ⣬¾ßÓÐËæÍÌÑʶ¯×÷×ÝÏòµÄ¿ÉËÜÐÔ£¬¿ÉÃ÷ÏÔ¼õÇáÊõºó²»ÊʸС£
3Ö§¼ÜÖÃÈë·½·¨
¸ßλʳ¹ÜÖ§¼Ü¶ÔÖ§¼ÜλÖõĿíÈݶȽÏС£¬ÉԸ߻áÒýÆðÊõºóÍÌÑÊÌÛÍ´£¬ÉԵͿÉÄܵ¼ÖÂÖ§¼ÜÏòÏÂÒÆÎ»¡£ÓÃÆÕͨÖÃÈëÆ÷ÊÍ·ÅÖ§¼Üµ½Ò»¶¨³Ì¶ÈºóÔòÄÑÒÔµ÷ÕûÖ§¼ÜλÖá£ÕâÊÇÒòΪ֧¼ÜµÄÕÅ¿ª²¿·Ö²»ÄÜÔÙËõ»ØÇʹܣ¬ÕâʱÔÙÓÃÁ¦ÉÏÏÂÒÆ¶¯»áÔì³Éʳ¹ÜµÄËðÉË¡£ÁíÍâÍøÖù×´Ö§¼Ü³¤¶ÈºÍÁ½¶ËµÄλÖÃÔÚÖ§¼ÜÊÍ·Åǰºó±ä»¯½Ï´ó£¬Ò²ÐèÒªÔÚÊõÖе÷Õû¡£²ÉÓøÄÁ¼µÄÖÃÈë×°Öã¬ÓÉÓÚÖ§¼Üºó·½Á¬ÓÐË¿Ïߣ¬À¶¯Ë¿ÏßÖ§¼Ü¼´Ëæ×ÅËõ»ØÍâÇʹܣ¬¿É·½±ãµØÔÚÊõÖе÷ÕûÖ§¼ÜλÖÃÖ±µ½ÂúÒâ¡£
ʳ¹Ü°©ÍíÆÚ¿ÉÇÖ·¸ºÍѹÆÈÆø¹Ü¡£Îª·Àֹʳ¹ÜÖ§¼ÜÖÃÈëºó¿ÉÄÜÔì³ÉµÄÆø¹Ü½øÒ»²½ÏÁÕ£¬ÊõǰӦÔÚCTÉÏÈÏÕæ¹Û²ì²¡±äÓëÆø¹ÜµÄ¹ØÏµ¡£¸ßλʳ¹ÜÖ§¼Ü¿Ú¾¶ÒÔ²»³¬¹ý15mmΪÒË¡£×îºÃÏÈÊÔÐÐÇòÄÒÀ©ÕÅ£¬¹Û²ìÎÞºôÎüÀ§ÄÑ£¬È·Èϰ²È«ºóÔÙÖÃÈëÖ§¼Ü¡£
²Î¿¼ÎÄÏ×
1. ÑïÈʽܣ¬ÕźêÖ¾£¬»Æ¿¡£¬µÈ . ±»¸²Ö§¼Ü³ÉÐÎÊõÔÚʳ¹Ü°©¹ÃÏ¢ÖÎÁÆÖеÄÓ¦ÓÃ[J]. Öлª·ÅÉäѧÔÓÖ¾ £¬1995 £¬29£¨7£©£º161~164 .
2. Song HY, Do YS, Han YM, et al. Covered expandable esophageal metallic stent tubes: experiences in 110 patients [J]. Radiology, 1994, 193(3):689~695.
3. µ¥ºè£¬ÂÞÅô·É£¬ÀîÑåºÀ.Ö÷±à. ÁÙ´²½éÈëÖÎÁÆÑ§[M]. µÚÒ»°æ.¹ãÖÝ£º¹ã¶«¿Æ¼¼³ö°æÉ磬1997£¬11£º30~32
4. ËïÐËÍú£¬´Þ½ø¹ú. Ïû»¯µÀÏÁÕ£¬¹£×èÇòÄÒÀ©Õż°ÄÚÖ§¼ÜÖÃÈëµÄÁÙ´²Ñ¡Ôñ[J]. ½éÈë·ÅÉäѧÔÓÖ¾£¬1998£¬7£¨4£©£º229~230
5. ÖйúÒ½¿Æ´óѧ.Ö÷±à.ÈËÌå½âÆÊѧ[M]. µÚÒ»°æ.±±¾©£ºÈËÃñÎÀÉú³ö°æÉ磬1978£¬ 12£º159~160
6. ³ÌÓ¢Éý£¬Ã«°®Î䣬ÑîÈʽܣ¬µÈ. 賦µÀÏÁÕ»ò¹£×èÄÚÖ§¼ÜÖÃÈëÊõºó³£¼û²¢·¢Ö¢¼°Æä´¦Àí[J]. ½éÈë·ÅÉäѧÔÓÖ¾£¬1998£¬7£¨1£©£º17~21
TAG: ʳ¹ÜÏÁÕ ¸ßλ ʳ¹ÜÖ×Áö Ö§¼Ü ·½·¨










